Therefore, liraglutide and insulin may regulate glucolipid metabolism and attenuate oxidative stress and inflammatory state in the liver of T1DM mice by activating the Wnt/β-catenin signaling pathway, thereby ameliorating hepatocyte degeneration and apoptosis. Here, INS is linked to type 1 diabetes mellitus.